LEOPOLDO
PÉREZ DE ISLA
Profesor asociado de Ciencias de la Salud
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (12)
2023
-
Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study
European journal of preventive cardiology, Vol. 30, Núm. 4, pp. 320-328
2021
-
Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study
Atherosclerosis, Vol. 317, pp. 52-58
-
Lipoprotein(a), LDL-cholesterol, and hypertension: Predictors of the need for aortic valve replacement in familial hypercholesterolaemia
European Heart Journal, Vol. 42, Núm. 22, pp. 2201-2211
2020
-
Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry
Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 828-834
2019
-
Bicuspid aortic valve behaviour in elite athletes
European Heart Journal Cardiovascular Imaging, Vol. 20, Núm. 7, pp. 772-780
-
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study
Journal of Clinical Lipidology, Vol. 13, Núm. 6, pp. 989-996
2018
-
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study
Journal of Clinical Lipidology, Vol. 12, Núm. 4, pp. 948-957
2017
-
Consecución de objetivos terapéuticos de colesterol LDL en niños y adolescentes con hipercolesterolemia familiar. Registro longitudinal SAFEHEART
Revista Espanola de Cardiologia, Vol. 70, Núm. 6, pp. 444-450
-
Predicting cardiovascular events in familial hypercholesterolemia: The SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study)
Circulation, Vol. 135, Núm. 22, pp. 2133-2144
2016
-
Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART registry follow-up
Journal of the American College of Cardiology, Vol. 67, Núm. 11, pp. 1278-1285
-
Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry
Journal of Clinical Lipidology, Vol. 10, Núm. 4, pp. 953-961
2014
-
Hiperlipidemia familiar combinada: documento de consenso
Atencion Primaria, Vol. 46, Núm. 8, pp. 440-446